Anti-DERL3 monoclonal antibody

Pre-made anti-DERL3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DERL3/DERL3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0685-Ab-1/ GM-Tg-hg-IP0685-Ab-2Anti-Human DERL3 monoclonal antibodyHuman
GM-Tg-rg-IP0685-Ab-1/ GM-Tg-rg-IP0685-Ab-2Anti-Rat DERL3 monoclonal antibodyRat
GM-Tg-mg-IP0685-Ab-1/ GM-Tg-mg-IP0685-Ab-2Anti-Mouse DERL3 monoclonal antibodyMouse
GM-Tg-cynog-IP0685-Ab-1/ GM-Tg-cynog-IP0685-Ab-2Anti-Cynomolgus/ Rhesus macaque DERL3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0685-Ab-1/ GM-Tg-felg-IP0685-Ab-2Anti-Feline DERL3 monoclonal antibodyFeline
GM-Tg-cang-IP0685-Ab-1/ GM-Tg-cang-IP0685-Ab-2Anti-Canine DERL3 monoclonal antibodyCanine
GM-Tg-bovg-IP0685-Ab-1/ GM-Tg-bovg-IP0685-Ab-2Anti-Bovine DERL3 monoclonal antibodyBovine
GM-Tg-equg-IP0685-Ab-1/ GM-Tg-equg-IP0685-Ab-2Anti-Equine DERL3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0685-Ab-1/ GM-Tg-hg-IP0685-Ab-2; GM-Tg-rg-IP0685-Ab-1/ GM-Tg-rg-IP0685-Ab-2;
GM-Tg-mg-IP0685-Ab-1/ GM-Tg-mg-IP0685-Ab-2; GM-Tg-cynog-IP0685-Ab-1/ GM-Tg-cynog-IP0685-Ab-2;
GM-Tg-felg-IP0685-Ab-1/ GM-Tg-felg-IP0685-Ab-2; GM-Tg-cang-IP0685-Ab-1/ GM-Tg-cang-IP0685-Ab-2;
GM-Tg-bovg-IP0685-Ab-1/ GM-Tg-bovg-IP0685-Ab-2; GM-Tg-equg-IP0685-Ab-1/ GM-Tg-equg-IP0685-Ab-2
Products NameAnti-DERL3 monoclonal antibody
Formatmab
Target NameDERL3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DERL3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0685-Ag-1Recombinant multi-species DERL3/ C22orf14/ IZP6 protein


    Target information

    Target IDGM-IP0685
    Target NameDERL3
    Gene ID91319,70377,690315,699316,486406,101089806,614334
    Gene Symbol and Synonyms1810006I20Rik,1810063P04Rik,C22orf14,DERL3,derlin-3,IZP6,LLN2
    Uniprot AccessionQ96Q80,Q0P5E4
    Uniprot Entry NameDERL3_HUMAN,DERL3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000099958
    Target ClassificationN/A

    The target: DERL3, gene name: DERL3, also named as C22orf14, IZP6, LLN2, derlin-3. The protein encoded by this gene belongs to the derlin family, and resides in the endoplasmic reticulum (ER). Proteins that are unfolded or misfolded in the ER must be refolded or degraded to maintain the homeostasis of the ER. This protein appears to be involved in the degradation of misfolded glycoproteins in the ER. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.